Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5683450 | Revista Clínica Española | 2017 | 4 Pages |
Abstract
In clinical practice, low-molecular-weight heparins are used relatively frequently in patients with atrial fibrillation to prevent embolic events. In this article, it is revised the available evidence in the following clinical situations: rapid onset of anticoagulation, bridging therapy (replacing long-term oral anticoagulant therapy around an invasive procedure) and transesophageal echocardiography-guided cardioversion.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
J.M. Calvo Romero,